Callanga, Jerlyn R.

HRN: 08-39-75  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/19/2023
CEFTRIAXONE 1G (VIAL)
01/19/2023
01/26/2023
IV
2 G
Q24
Preseptal Cellitis; T/C Periodontal Abscess Left
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Eye, Ear, Nose, Throat, & MouthDisseminated Systemic Infection    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: